Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: Effect of vaccination with HIV-1 gp 120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus

Journal of General Virology

Volumn 79, Issue 3, 1998, Pages 423-432

  Stott, E J ^a   Almond, N ^a   Kent, K ^a   Walker, B ^a   Hull, R ^a   Rose, J ^a   Silvera, P ^a   Sangster, R ^a   Corcoran, T ^a   Lines, J ^a   Silvera, K ^a   Luciw, P ^b   Murphy Corb, M ^c   Momin, P ^d   Bruck, C ^d  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAMUSCULAR DRUG ADMINISTRATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 15444349408     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-3-423     Document Type: Article

References (43)

1. Agy, M. B., Frumkin, L. R., Corey, L., Coombs, R. W., Wolinsky, S. M., Koehler, J., Morton, W. R. & Katze, M. G. (1992). Infection of Macaca nemestrina by human immunodeficiency virus type 1. Science 257, 103-100.
2. Ahmed, S., Lohman, B., Marthas, M., Giavedoni, L., El-awad, Z., Haigwood, N., Scandella, C., Gardner, M., Luciw, P. & Yilma, T. (1994). Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Research and Human Retroviruses 10, 195-204.
3. Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K. & Eichberg, J. W. (1990). Protection of chimpanzee from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345, 622-625.
4. Berman, P. W., Murthy, K. K., Wrin, T., Vennari, J. C., Cobb, E. K., Eastman, D. J., Champe, M., Nakamura, G. R., Davison, D., Powell, M. F., Bussiere, J., Francis, D. P., Matthews, T., Gregory, T. J. & Obijeski, J. F. (1996). Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. Journal of Infectious Diseases 173, 52-59.
5. Biti, R., French, R., Young, J., Bennetts, B. & Steward, G. (1997). HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Medicine 3, 252-253.
6. Bootman, J. & Kitchin, P. (1992). An international collaborative study to assess a set of reference reagents for HIV-1 PCR. Journal of Virological Methods 37, 23-42.
7. Bruck, C., Thiriart, C., Fabry, L., Franchotte, M., Pala, P., Van Opstal, O., Culp, J., Rosenberg, M., De Wilde, M., Heid, P. & Heeney, J. (1994). HIV-1 envelope elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12, 1141-1148.
8. Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Hunt, R. D., Kanki, P. J., Essex, M. & Desrosiers, R. G. (1985). Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1201-1204.
9. Daniel, M., Mazzara, G., Meredith, S., Sehgal, P., Kodama, T., Panicali, D. & Desrosiers, R. (1994). High titre immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Research and Human Retrovirsuses 10, 839-851.
10. Dunn, C. S., Beyer, C., Kieny, M.-P., Gloeckler, L., Schmitt, D., Gut, J. P., Kim, A. & Aubertin, A.-M. (1996). High viral load and CD4 lymphopaemia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env. rev, tat and vpu genes from HIV-1 LAI. Virology 223, 351-361.
11. Gardner, M. B. (1993). The importance of non human primate research in the battle against AIDS: a historical perspective. Journal of Medical Primatology 22, 86-91.
12. Giavedoni, L., Planelles, V., Haigwood, N., Ahmed, S., Kluge, J., Marthas, M., Gardner, M., Luciw, P. & Yilma, T. (1993). Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. Journal of Virology 67, 577-583.
13. Girard, M., Kieny, M.-P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T. & Muchmore, E. (1991). Immunization of chimpanzee confers protection against challenge with human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 88, 542-546.
14. Girard, M., Meigneir, B., Barre-Sinoussi, F., Kieny, M.-P., Matthews, T., Muchmore, E., Nara, P. L., Wei, Q., Rimsky, L. & Weinhold, K. (1995). Vaccine induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. Journal of Virology 69, 6239-6248.
15. Gotch, F., Hovell, R., Delchambre, M., Silvera, P. & McMichael, A, J. (1991). Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. AIDS 5, 317-320.
16. Groenink, M., Andeweg, A. C., Fouchier, R. A. M., Broersen, S., van der Jagt, R. C. M., Schuitemaker, H., de Goede, R. E. Y., Bosch, M. L., Huisman, G. H. & Tersmette, M. (1992). Phenotype associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain. Journal of Virology 66, 6175-6180.
17. Hedman, K. & Rousseau, S. A. (1989). Measurement of avidity of specific IgG for verification of recent primary rubella. Journal of Medical Virology 27, 288-292.
18. Heeney, J. L. (1996). Primate models for AIDS vaccine development. AIDS 10, S115-122.
19. Hu, S.-L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L. R., Morton, W. R. & Benveniste, R. E. (1992). Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255, 456-459.
20. Israel, Z., Edmonson, P., Maul, D., O'Neil, S., Mossman, S., Thiriart, C., Fabry, L., van Opstal, O., Bruck, C., Bex, F., Burny, A., Fultz, P., Mullins, J. & Hoover, E. (1994). Incomplete protection, but suppression of virus burden by subunit simian immunodeficiency virus vaccines. Journal of Virology 68, 1843-1853.
21. Katrak, K., Mahon, B. P., Jones, E. C., Brautigam, S. & Mills, K. H. G. (1992). Preparative separation of foreign antigens for highly efficient presentation to T-cells in vitro. Journal of Immunological Methods 156, 247-254.
22. Kent, K. A., Kitchin, P., Mills, K. H. G., Page, M., Taffs, L. F., Corcoran, T., Silvera, P., Flanagan, B., Powell, C., Rose, J., Ling, C., Aubertin, A. M. & Stott, E. J. (1994). Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protected against challenge with SIVmac251. AIDS Research and Human Retroviruses 10, 189-194.
23. Letvin, N. L., Montefiori, D. C., Yasutomi, Y., Perry, H. C., Davies, H.-E., Lekutis, C., Alroy, M., Freed, D. C., Lord, C. I., Handt, L. K., Liu, M. A. & Shiver, J. W. (1997). Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proceedings of the National Academy of Sciences, USA 94, 9378-9383.
24. Li, J., Lord, C. I., Haseltine, W., Letvin, N. L. & Sodroski, J. (1992). Infection of cynomolgus macaques with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoprotein. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 5, 639-646.
25. Liu, R., Paxton, W. A., Choe, S., Ceradinia, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. & Landan, N. R. (1996). Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 86, 367-377.
26. Lu, Y., Salvato, M. S., Pauza, C. D., Li, J., Sodroski, J., Manson, K., Wyand, M., Letvin, N., Jenkins, S., Tonzian, N., Chutkowski, C., Kushner, N., Lefile, M., Payne, L. G. & Roberts, B. (1996). Utility of SHIV for testing HIV-1 vaccine candidates in macaques. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12, 99-106.
27. Luciw, P. A., Pratt-Lowe, E., Shaw, K. E. S., Levy, J. A. & Cheng-Mayer, C. (1995). Persistent infection of rhesus macaques with T-cell line tropic and macrophage tropic clones of simian/human immunodeficiency viruses (SHIV). Proceedings of the National Academy of Sciences, USA 92, 7490-7494.
28. Mills, K. H. G., Page, M., Chan, W. L., Kitchin, P., Stott, E. J., Tafs, L. F., Jones, W., Rose, J., Ling, C., Silvera, P., Corcoran, T., Flanagan, B., Burny, A., Bex, F., Delchambre, M., Van Opstal, O., Fabry, L., Thiriart, C., Delers, A., DeWilde, M. & Bruck, C. (1992). Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant Env and Gag proteins. Journal of Medical Primatology 21, 50-58.
29. Mills, K. H. G., Page, M., Kitchin, P., Chan, W. L., Jones, W., Silvera, P., Corcoran, T., Flanagan, B., Ling, C., Thiriart, C., DeWilde, M., Bruck, C., Rud, E., Clarke, B. & Stott, E. J. (1993). Immunization of macaques with SIV env recombinants: specificity of T-cell and antibody responses and evaluation of protective efficacy. Journal of Medical Primatology 22, 104-109.
30. Ranjbar, S., Jones, S., Stott, E. J. & Almond, N. (1997). The construction and evaluation of SIV/HIV chimeras which express the envelope of European HIV-1 isolates. AIDS Research and Human Retroviruses 12, 797-805.
31. Reimann, K. A., Li, J. T., Veaze, R., Halloran, M., Park, I. W., Karlsson, G. B., Sodroski, J. & Letvin, N. L. (1996). A chimeric simian/human immunodeficiency virus expressing primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. Journal of Virology 70, 6922-6928.
32. Robert-Guroff, M., Natuk, R. J., Myagkikh, M. and others (1995). Adenovirus-HIV-1mn env recombinants and a SF2 gp120 boost protect chimpanzees from a SF2 challenge. AIDS Research and Human Retroviruses 11, S136.
33. Rose, J., Silvera, P., Flanagan, B., Kitchin, P. & Almond, N. (1995). The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. Journal of Virological Methods 51, 229-240.
34. Sakuragi, S., Shibata, R., Mukai, R., Komatsu, T., Fukasawa, M., Saki, H., Sakuragi, J.-I., Kawamura, M., Ibuki, K., Hayami, M. & Adachi, A. (1992). Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. Journal of General Virology 73, 2983-2987.
35. Schultz, A. M. & Stott, E. J. (1994). Primate models for AIDS vaccines. AIDS 8 (Suppl. 1), S203-S212.
36. Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A. & Adachi, A. (1991). Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. Journal of Virology 65, 3514-3520.
37. Silvera, P., Flanagan, B., Kent, K., Rud, E., Powell, C., Corcoran, T., Bruck, C., Thiriart, C., Haigwood, N. L. & Stott, E. J. (1994). Final analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques. AIDS Research and Human Retroviruses 10, 1295-1304.
38. Stott, E. J. (1994). Towards a vaccine against AIDS: lessons from simian immunodeficiency virus vaccines. Current Topics in Microbiology and Immunology 188, 221-237.
39. Stott, J. & Almond, N. (1995). Assessing animal models of AIDS. Nature Medicine 1, 295-297.
40. Stott, E. J., Chan, W. L., Mills, K. H. G., Page, M., Taffs, L. F., Cranage, M., Greenaway, P. & Kitchin, P. A. (1990). Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by whole fixed cell vaccine. Lancet 336, 1538-1541.
41. Trkola, A., Dragic, T., Arthos, J., Binley, J., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J. & Moore, J. P. (1996). CD4-dependent antibody sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 384, 184-187.
42. Walker, M. C. & Fast, P. (1994). Clinical trials of candidate AIDS vaccines. AIDS 8 (Suppl 1), S213-S236.
43. Warren, J. T. & Levinson, M. A. (1995). Fourth annual survey of worldwide HIV, SIV and SHIV challenge studies in vaccinated non-human primates. Journal of Medical Primatology 24, 150-168.